Laboratory
Leveraging Professor Zhu Yizhun’s profound research achievements and academic resources, InnoDrug has established a joint laboratory with Macau University of Science and Technology, based on the State Key Laboratory of Quality Research in Chinese Medicine. This partnership is dedicated to advancing the development and research of first-in-class drugs, while continuously delivering cutting-edge R&D outcomes to the Group’s product pipeline.

- China’s Only State Key Laboratory in Chinese Medicine
- Nobel Prize Pharmaceutical Laboratory
World-Leading First-in-Class Drug Development Platform
Access to advanced, state-of-the-art instrumentation and systems valued at over RMB 300 million from the State Key Laboratory. InnoDrug is investing over RMB 20 million to acquire cutting-edge equipment for the Natural Drug Discovery Industrial Laboratory.
Core Platforms
Proteomics Analysis
Metabolomics and
Glycomics Analysis
Mass Spectrometry and NMR
Spectroscopy Integration
Nano Chinese Medicine
Formulation